Epilepsy and gut bacteria: understanding treatment response
Part of Brain & nervous system clinical trials.
This study looks at how the bacteria in your gut relate to how well epilepsy treatments work. It compares people with newly diagnosed epilepsy (who haven't yet started medicine) to healthy people without epilepsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 79 years old.
- If you have epilepsy: you were just diagnosed and have not started any anti-seizure medicine (or had only one dose).
- If you are a control (no epilepsy): you have never had epilepsy or taken anti-seizure medicine.
- You have not used antibiotics or probiotics in the last 3 months.
- You do not have a stomach or bowel condition, have not had digestive surgery, and do not have obesity (BMI over 30) or type 2 diabetes.
- You are not pregnant, breastfeeding, on a strict exclusion diet, or using a feeding tube.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This study looks at how the gut and brain talk to each other in people with epilepsy, especially when seizures are hard to control. It may help find new ways to treat epilepsy by focusing on the gut.
This study uses a brain wave test (EEG) to see if it can predict how well anti-seizure medication will work for people newly diagnosed with epilepsy. It may help doctors choose the right medication sooner.
This study looks at the bacteria in your gut (the microbiome) in people with chronic gut conditions. Researchers want to understand how gut bacteria differ in these conditions to help improve treatments.
This trial is testing a new treatment made from human stem cells to see if it is safe and helpful for people whose seizures are not controlled by current medications. If you have drug-resistant epilepsy, this treatment might offer a new option.
This trial studies how a person's genes affect their response to the epilepsy drug valproate. The goal is to find the best dose for each patient to improve seizure control and reduce side effects.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.